- Solid Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Solid Biosciences Inc at Citi BioPharma Conference TranscriptSep 07, 2023
- Solid Biosciences Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Solid Biosciences Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Solid Biosciences Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) TranscriptApr 24, 2023
- Solid Biosciences Inc at Needham Healthcare Conference (Virtual) TranscriptApr 20, 2023
- Solid Biosciences Inc at BMO Capital Markets BioPharma Spotlight Series: Genetic Medicine Delivery (Virtual) TranscriptMar 28, 2023
- Solid Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Solid Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Solid Biosciences Inc To Acquire Aavantibio Inc Call TranscriptSep 30, 2022
- Q1 2022 Solid Biosciences Inc Earnings Call TranscriptApr 27, 2022$9.65 (-16.98%)Earnings
- Solid Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2022
- Solid Biosciences Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 28, 2021
- Solid Biosciences Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2021
- Q1 2021 Solid Biosciences Inc Earnings Call TranscriptMay 14, 2021$52.35 (-21.40%)Earnings
- Pfizer Inc, Avidity Biosciences, Sarepta Therapeutics, Solid Biosciences, and Ultragenyx Pharmaceutical at Guggenheim Partners Healthcare Talks: Genomic Medicines & Rare Disease (Virtual) TranscriptApr 01, 2021
- Solid Biosciences Inc. - Special Call TranscriptMar 15, 2021
- Solid Biosciences Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Solid Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2020 Solid Biosciences Inc Earnings Call TranscriptNov 05, 2020$48.6Earnings
- Solid Biosciences Inc Annual Shareholders Meeting TranscriptJun 16, 2020
- Solid Biosciences Inc. - Special Call TranscriptDec 18, 2019
- Solid Biosciences Inc. - Special Call TranscriptNov 12, 2019
Solid Biosciences Inc at BMO Capital Markets BioPharma Spotlight Series: Genetic Medicine Delivery (Virtual) Transcript
Good morning. My name is Bert Powell, and I'm the Global Director of Research here at BMO Capital Markets. So it's my pleasure to welcome you to today's Biopharma Spotlight Series on novel technologies for the delivery of genetic medicines.
It's an important new class of medicines that are the emerging technology in life sciences today. BMO Capital Markets biotech research analyst Kostas Biliouris will moderate all 4 of today's panel discussions. Each panel will take a deep dive with the companies who are leading the research and the development genetic medicines through adeno-associated viruses, where in a naturally occurring virus is converted into a delivery mechanism for genetic medicines, lipid nanoparticles were nanoparticles comprised of lipids and were used in COVID vaccines and other delivery platforms that can potentially address some of the limitations in adeno-associated viruses and lipid nanoparticles.
Our last panel today will focus on the drug delivery in the CNS space, and we look
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)